ALPMY
ASTELLAS PHARMA/ADR

322
Mkt Cap
$27.64B
Volume
70,356.00
52W High
$17.35
52W Low
$8.97
PE Ratio
12.83
ALPMY Fundamentals
Price
$15.43
Prev Close
$15.48
Open
$15.97
50D MA
$15.80
Beta
0.27
Avg. Volume
156,676.95
EPS (Annual)
$0.1859
P/B
2.46
Rev/Employee
$919,438.95
$22,390.70
Loading...
Loading...
News
all
press releases
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
Here is how Astellas Pharma Inc. (ALPMY) and Adlai Nortye Ltd. Sponsored ADR (ANL) have performed compared to their sector so far this year.
Zacks·16d ago
News Placeholder
More News
News Placeholder
Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?
Here is how Astellas Pharma Inc. (ALPMY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Zacks·1mo ago
News Placeholder
Japan’s Astellas Pharma hits 8-mth high on upbeat Q1 earnings
Investing.com-- Shares of Astellas Pharma Inc. (TYO:4503) jumped to an eight-month high on Thursday after the Japanese drugmaker reported robust first-quarter earnings, driven by strong sales of key cancer treatments and cost-cutting measures.
investing.com·9mo ago
News Placeholder
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Here is how Abbott (ABT) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
Zacks·9mo ago
News Placeholder
Is Alpha Cognition Inc. (ACOG) Outperforming Other Medical Stocks This Year?
Here is how Alpha Cognition Inc. (ACOG) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
Zacks·10mo ago
News Placeholder
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
Zacks·11mo ago
News Placeholder
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
Zacks·11mo ago
News Placeholder
Here's Why Astellas Pharma (ALPMY) Is a Great 'Buy the Bottom' Stock Now
Zacks·1y ago
<
...
1
>

Latest ALPMY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.